PancreatectomyNCT06738914
Twenty Years of Pancreatic Surgery in Iceland
An observational study of Pancreatectomy and Pancreatoduodenectomy, run by Linkoeping University.
Trial summary
A retrospective analysis of patients undergoing pancreatic operations in Landspitali University Hospital, Reykjavik, Iceland, between 2003 and 2022. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Pancreatectomy, Pancreatoduodenectomy, Distal Pancreatectomy (DP)
- How many people
- 244 participants
- Where
- No sites listed yet
- Study dates
- Jan 2003to Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients who have undergone pancreatic resection in Iceland between 2003-2022. For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.
Who may be able to join
- All patients who have undergone pancreatic resection in Iceland between 2003-2022.
- For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.
Who cannot join
None listed.
About this study
Official title: Twenty Years of Pancreatic Surgery in Iceland: a Retrospective Cohort Study
A retrospective analysis of patients undergoing pancreatic operations in Landspitali University Hospital, Reykjavik, Iceland, between 2003 and 2022.
What is being measured
The primary outcome is the main question the study is designed to answer.
Severe complications
Measured: 2003-2022
Short-term mortality
Measured: 2003-2022
Secondary outcomes (6)
Demographic, operative and postoperative data
Measured: 2003-2022
Oncological data and survival among patients with pancreatic and periampullary cancer
Measured: 2003-2022
Outcomes after pancreatic surgery among patients who underwent resection for cystic lesions
Measured: 2003-2022
Comparison of patients who underwent minimally invasive distal pancreatectomy during the study period to those who underwent open distal resection.
Measured: 2003-2022
Demographic and histopathological data as well as survival compared between patients with duodenal cancer who underwent resection and patients who did not.
Measured: 2003-2022
Trends over time in the usage of pancreatic and minimally invasive surgery as well as changes in outcomes.
Measured: 2003-2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Dec 2024
- Study startJan 2003
- Primary completionDec 2022
- Study completionDec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PancreatectomyStudies of the same condition, open and under way.
- More trials run by Linkoeping UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 244 participants (actual)
Sponsor and investigators
- Lead sponsor
- Linkoeping University
- Sponsor type
- Other government
- Collaborators
- Landspitali University Hospital
- Responsible party
- Principal investigator, Karin Johansen, Linkoeping University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06738914
- Sponsor's protocol ID
- VSN-24-124
- Status last verified
- Dec 2024
- First submitted
- 12 Dec 2024
- Last updated
- 24 Dec 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Not included in the ethical approval for the study.
Publications
Johansen K, Birgisson G, Haraldsdottir KH. Early implementation of laparoscopic left-sided pancreatectomy in a tertiary low-volume hospital. Scand J Surg. 2025 Sep;114(3):334-341. doi: 10.1177/14574969251343471. Epub 2025 May 26.
PubMed 40417843
Study at a glance
From the registry record, last updated by the sponsor on 24 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Twenty Years of Pancreatic Surgery in Iceland: a Retrospective Cohort Study
- ClinicalTrials.gov ID
- NCT06738914
- Acronym / sponsor ID
- VSN-24-124
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 244 participants (actual)
- Lead sponsor
- Linkoeping UniversityOther government
- Collaborators
- Landspitali University Hospital
- Study start
- Jan 2003 (actual)
- Primary completion
- Dec 2022 (actual)
- Study completion
- Dec 2022 (actual)
- First posted
- 18 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A retrospective analysis of patients undergoing pancreatic operations in Landspitali University Hospital, Reykjavik, Iceland, between 2003 and 2022.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients who have undergone pancreatic resection in Iceland between 2003-2022. For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.
Key inclusion criteria (2 listed)
- All patients who have undergone pancreatic resection in Iceland between 2003-2022.
- For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Severe complications
Time frame: 2003-2022
Short-term mortality
Time frame: 2003-2022
6 secondary outcomes
Demographic, operative and postoperative data
Time frame: 2003-2022
Oncological data and survival among patients with pancreatic and periampullary cancer
Time frame: 2003-2022
Outcomes after pancreatic surgery among patients who underwent resection for cystic lesions
Time frame: 2003-2022
Comparison of patients who underwent minimally invasive distal pancreatectomy during the study period to those who underwent open distal resection.
Time frame: 2003-2022
Demographic and histopathological data as well as survival compared between patients with duodenal cancer who underwent resection and patients who did not.
Time frame: 2003-2022
Trends over time in the usage of pancreatic and minimally invasive surgery as well as changes in outcomes.
Time frame: 2003-2022
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Dec 2024.
- Derived from this study: PubMed 40417843Johansen K, Birgisson G, Haraldsdottir KH. Early implementation of laparoscopic left-sided pancreatectomy in a tertiary low-volume hospital. Scand J Surg. 2025 Sep;114(3):334-341. doi: 10.1177/14574969251343471. Epub 2025 May 26.
- Individual participant dataSharing planned: No. Not included in the ethical approval for the study.
Related trials for Pancreatectomy
RecruitingObservational study
Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy
Pancreatic Neoplasms, Distal Pancreatectomy (DP)
Recruiting
Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study
Pancreatic Diseases
Not yet recruitingObservational study
European Appleby Registry for Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Cyst of Pancreas, Pancreatectomy
Active, not recruitingPhase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Chronic Pancreatitis, Mesenchymal Stem Cells
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Pancreatectomy and Pancreatoduodenectomy, run by Linkoeping University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Severe complications (time frame: 2003-2022). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06738914, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2024.